Topical decongestant

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 02:13, 17 August 2019 (Add: pmc. | You can use this bot yourself. Report bugs here.| Activated by User:Corvusphalanx). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Topical decongestants are decongestants applied directly to the nasal cavity. Their effectiveness by themselves in the common cold appears to have a small benefit in adults.[1]

Topical decongestants should only be used by patients for a maximum of 5–7 days in a row, because rebound congestion may occur in the form of rhinitis medicamentosa. When used in adults for a short period of time side effects appear to be few.[1]

Mechanism of action

Topical decongestants are vasoconstrictors, and work by constricting the blood vessels within the nasal cavity

Examples

See also

References

  1. ^ a b Deckx, L; De Sutter, AI; Guo, L; Mir, NA; van Driel, ML (17 October 2016). "Nasal decongestants in monotherapy for the common cold". The Cochrane Database of Systematic Reviews. 10: CD009612. doi:10.1002/14651858.CD009612.pub2. PMC 6461189. PMID 27748955.


Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Topical_decongestant&oldid=911178229"